Nurse Practitioner, Family · Orange, CT
NPI
1245527993
Since 2011
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
236 Boston Post Road, Unit 1a
Orange, CT, 06477
Phone (475) 882-6824
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
901 services
Medicare patients, 2024
150
Average age 61
Drug cost, 2024
$566K
2,463 prescriptions
Company payments, 2025
$121
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kimberly M Gambino was code 99214 (office e&m - established), 582 times for 146 patients. In total Kimberly M Gambino billed 901 services in 5 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 582 | 146 | $77.75 | $45K |
| 80307 Drug Tests | Office | 290 | 118 | $60.35 | $18K |
| 99205 Office E&M - New | Office | 18 | 18 | $146.49 | $2,637 |
By year: 2022 $19K for 316 services; 2023 $57K for 757 services; 2024 $66K for 901 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 290 | 118 | $60.35 | $18K |
Medicare prescription drug claims, 2024
In 2024, the drug Kimberly M Gambino prescribed most often to Medicare patients was Oxycodone Hcl, with 481 prescriptions and refills. In total Kimberly M Gambino wrote 2,463 Medicare prescriptions that cost $566K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 481 | 481 | 166 | $7,687 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 215 | 215 | 75 | $5,423 |
| Belbuca Buprenorphine Hcl | 195 | 195 | 84 | $173K |
| Gabapentin Generic | 163 | 189 | 57 | $1,954 |
| Buprenorphine Generic | 135 | 135 | 61 | $33K |
| Baclofen Generic | 95 | 111 | 42 | $1,420 |
| Cyclobenzaprine Hcl Generic | 93 | 99 | 41 | $813 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 86 | 86 | 22 | $11K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 77 | 77 | 32 | $1,853 |
| Tramadol Hcl Generic | 74 | 74 | 34 | $1,010 |
| Pregabalin Generic | 70 | 74 | 27 | $1,890 |
| Diclofenac Sodium Generic | 64 | 66 | 20 | $11K |
| Tizanidine Hcl Generic | 56 | 62 | 22 | $2,327 |
| Ztlido Lidocaine | 55 | 57 | 17 | $58K |
| Linzess Linaclotide | 54 | 60 | 21 | $33K |
Brand drugs: 596 claims; generic drugs: 1,867 claims; opioid claims: 1,395.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kimberly M Gambino $121 ($121 in general payments such as food, travel and fees) from 2 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $93.15.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.